172 related articles for article (PubMed ID: 28978132)
1. Expression profiles analysis reveals an integrated miRNA-lncRNA signature to predict survival in ovarian cancer patients with wild-type BRCA1/2.
Guo L; Peng Y; Meng Y; Liu Y; Yang S; Jin H; Li Q
Oncotarget; 2017 Sep; 8(40):68483-68492. PubMed ID: 28978132
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of lncRNA expression profiles reveals a novel lncRNA signature to discriminate nonequivalent outcomes in patients with ovarian cancer.
Zhou M; Sun Y; Sun Y; Xu W; Zhang Z; Zhao H; Zhong Z; Sun J
Oncotarget; 2016 May; 7(22):32433-48. PubMed ID: 27074572
[TBL] [Abstract][Full Text] [Related]
3. Characterization of BRCA1/2-Directed ceRNA Network Identifies a Novel Three-lncRNA Signature to Predict Prognosis and Chemo-Response in Ovarian Cancer Patients With Wild-Type BRCA1/2.
Zhang M; Wang G; Zhu Y; Wu D
Front Cell Dev Biol; 2020; 8():680. PubMed ID: 32850807
[TBL] [Abstract][Full Text] [Related]
4. The BRCA1/2-directed miRNA signature predicts a good prognosis in ovarian cancer patients with wild-type BRCA1/2.
Gu Y; Zhang M; Peng F; Fang L; Zhang Y; Liang H; Zhou W; Ao L; Guo Z
Oncotarget; 2015 Feb; 6(4):2397-406. PubMed ID: 25537514
[TBL] [Abstract][Full Text] [Related]
5. Expression profiles analysis of long non-coding RNAs identified novel lncRNA biomarkers with predictive value in outcome of cutaneous melanoma.
Ma X; He Z; Li L; Yang D; Liu G
Oncotarget; 2017 Sep; 8(44):77761-77770. PubMed ID: 29100423
[TBL] [Abstract][Full Text] [Related]
6. A long non-coding RNA expression signature to predict survival of patients with colon adenocarcinoma.
Xue W; Li J; Wang F; Han P; Liu Y; Cui B
Oncotarget; 2017 Nov; 8(60):101298-101308. PubMed ID: 29254165
[TBL] [Abstract][Full Text] [Related]
7. Integrated analysis of long non-coding RNA‑associated ceRNA network reveals potential lncRNA biomarkers in human lung adenocarcinoma.
Sui J; Li YH; Zhang YQ; Li CY; Shen X; Yao WZ; Peng H; Hong WW; Yin LH; Pu YP; Liang GY
Int J Oncol; 2016 Nov; 49(5):2023-2036. PubMed ID: 27826625
[TBL] [Abstract][Full Text] [Related]
8. A potential signature of eight long non-coding RNAs predicts survival in patients with non-small cell lung cancer.
Zhou M; Guo M; He D; Wang X; Cui Y; Yang H; Hao D; Sun J
J Transl Med; 2015 Jul; 13():231. PubMed ID: 26183581
[TBL] [Abstract][Full Text] [Related]
9. Identification and validation of potential prognostic lncRNA biomarkers for predicting survival in patients with multiple myeloma.
Zhou M; Zhao H; Wang Z; Cheng L; Yang L; Shi H; Yang H; Sun J
J Exp Clin Cancer Res; 2015 Sep; 34(1):102. PubMed ID: 26362431
[TBL] [Abstract][Full Text] [Related]
10. A six-long non-coding RNAs signature as a potential prognostic marker for survival prediction of ER-positive breast cancer patients.
Zhong L; Lou G; Zhou X; Qin Y; Liu L; Jiang W
Oncotarget; 2017 Sep; 8(40):67861-67870. PubMed ID: 28978079
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive analysis of lncRNA-mRNA co-expression patterns identifies immune-associated lncRNA biomarkers in ovarian cancer malignant progression.
Guo Q; Cheng Y; Liang T; He Y; Ren C; Sun L; Zhang G
Sci Rep; 2015 Dec; 5():17683. PubMed ID: 26631459
[TBL] [Abstract][Full Text] [Related]
12. A novel signature of two long non-coding RNAs in BRCA mutant ovarian cancer to predict prognosis and efficiency of chemotherapy.
Pan Y; Jia LP; Liu Y; Han Y; Li Q; Zou Q; Zhang Z; Huang J; Deng Q
J Ovarian Res; 2020 Sep; 13(1):112. PubMed ID: 32950050
[TBL] [Abstract][Full Text] [Related]
13. A long non-coding RNA signature for predicting survival in patients with colorectal cancer.
Wang YL; Shao J; Wu X; Li T; Xu M; Shi D
Oncotarget; 2018 Apr; 9(31):21687-21695. PubMed ID: 29774095
[TBL] [Abstract][Full Text] [Related]
14. A long non-coding RNA signature in glioblastoma multiforme predicts survival.
Zhang XQ; Sun S; Lam KF; Kiang KM; Pu JK; Ho AS; Lui WM; Fung CF; Wong TS; Leung GK
Neurobiol Dis; 2013 Oct; 58():123-31. PubMed ID: 23726844
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive analysis of a novel four-lncRNA signature as a prognostic biomarker for human gastric cancer.
Miao Y; Sui J; Xu SY; Liang GY; Pu YP; Yin LH
Oncotarget; 2017 Sep; 8(43):75007-75024. PubMed ID: 29088841
[TBL] [Abstract][Full Text] [Related]
16. A 15-long non-coding RNA signature to improve prognosis prediction of cervical squamous cell carcinoma.
Mao X; Qin X; Li L; Zhou J; Zhou M; Li X; Xu Y; Yuan L; Liu QN; Xing H
Gynecol Oncol; 2018 Apr; 149(1):181-187. PubMed ID: 29525275
[TBL] [Abstract][Full Text] [Related]
17. A five-long non-coding RNA signature to improve prognosis prediction of clear cell renal cell carcinoma.
Shi D; Qu Q; Chang Q; Wang Y; Gui Y; Dong D
Oncotarget; 2017 Aug; 8(35):58699-58708. PubMed ID: 28938589
[TBL] [Abstract][Full Text] [Related]
18. Prediction of clinical outcome and survival in soft-tissue sarcoma using a ten-lncRNA signature.
He RQ; Wei QJ; Tang RX; Chen WJ; Yang X; Peng ZG; Hu XH; Ma J; Chen G
Oncotarget; 2017 Oct; 8(46):80336-80347. PubMed ID: 29113307
[TBL] [Abstract][Full Text] [Related]
19. Integrated analysis of competing endogenous RNA network revealing lncRNAs as potential prognostic biomarkers in human lung squamous cell carcinoma.
Sui J; Xu SY; Han J; Yang SR; Li CY; Yin LH; Pu YP; Liang GY
Oncotarget; 2017 Sep; 8(39):65997-66018. PubMed ID: 29029488
[TBL] [Abstract][Full Text] [Related]
20. Integrated analysis of long non-coding RNA competing interactions reveals the potential role in progression of human gastric cancer.
Li CY; Liang GY; Yao WZ; Sui J; Shen X; Zhang YQ; Peng H; Hong WW; Ye YC; Zhang ZY; Zhang WH; Yin LH; Pu YP
Int J Oncol; 2016 May; 48(5):1965-76. PubMed ID: 26935047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
